Amarin Corporation PLC (AMRN) Earns Buy Rating from HC Wainwright

Amarin Corporation PLC (AMRN) Earns Buy Rating from HC Wainwright


HC Wainwright currently has a $10.00 price objective on the biopharmaceutical company's stock. Several other brokerages have also issued reports on AMRN.



from Biotech News